TM Capital Advises C.B. Fleet in its Sale to Gryphon InvestorsOctober 2014 | News & Press
TM Capital, a leading middle market investment banking firm with offices in New York, Boston and Atlanta, served as exclusive financial advisor to C.B. Fleet Company, Inc. (“Fleet Laboratories”) – a leading manufacturer and marketer of consumer branded, OTC health and personal care products – in its sale to Gryphon Investors, a San Francisco-based private equity firm. Family owned for 145 years, the Company’s brands are trusted market leaders across key consumer categories. We assisted management and the Board of Directors in attracting an institutional partner which will provide enhanced financial resources while maintaining Fleet Laboratories’ rich history and strong ties to the Lynchburg, VA community. This is another in a series of recent transactions highlighting TM Capital’s differentiated expertise in realizing premium values for world class branded consumer products companies.
– Fleet Laboratories owns a portfolio of iconic brands in the feminine hygiene, gastrointestinal care and infant care categories including Summer’s Eve®, Fleet®, Pedia-Lax®, Phazyme® and Boudreaux’s®
– The Company’s products, which are sold in over 50 countries worldwide, enjoy unmatched legacies of trust and efficacy with consumers and medical professionals
– Gryphon Investors, with over $1.4 billion of cumulative equity commitments, focuses on acquisitions of middle-market companies in partnership with experienced management teams to build leading platforms
– This is the fourth transaction TM Capital has completed for Fleet Laboratories
For more information, please visit www.tmcapital.com/transactions.
What Our Clients are Saying
“Once you have made the difficult decision to sell a 145-year-old family business with global reach and over 60 shareholders, your next step is to retain a first class financial advisor who understands your company and its industry, which has deep experience in M&A transactions and, most importantly, whom you can trust implicitly. TM Capital has been our go-to banker for strategic transactions for the past 20 years, while also providing consistent guidance on a host of financial issues. For the Board of Directors of C.B. Fleet, selecting TM was an easy decision.”
– William R. Chambers,
Chairman, C.B. Fleet Company, Inc.
About TM Capital
TM Capital Corp. is a partner-owned investment banking firm based in New York, Boston and Atlanta, which has completed over 250 transactions with a combined value in excess of $16 billion. Since 1989, we have advised clients navigating a full range of critical transactions, including complex mergers, acquisitions, debt and equity financings, minority and majority recapitalizations, restructurings, and advisory services including takeover defense, fairness and solvency opinions, valuations, as well as litigation support. We have built deep industry expertise in key sectors and our team regularly publishes research highlighting current and emerging trends in targeted industries and markets. TM Capital is a member firm of M&A International Inc., the world’s leading alliance of mid-market investment banks with over 600 M&A professionals in 40 countries. Members have closed over 1,300 transactions totaling more than $75 billion in value over the past five years.